Gilead Sciences, Inc.
Prices from Yahoo Finance's public feed. Some prices may be delayed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All GILD news ›Centerburg allows no points against Mt. Gilead
Defense dominated as Centerburg pitched a 46-0 shutout of Mt. Gilead during this Ohio football game on Oct. 3. Centerburg steamrolled in front of Mt. Gilead 32-0 to begin the second quarter. The Trojans opened a mammoth 39-0 gap over the…
Centerburg edges Mount Gilead to remain atop KMAC ladder
MOUNT GILEAD — Chaos. That may be the appropriate word to use when even the head coach was blocked from viewing one of the biggest plays of the season thus far. With the visiting Centerburg Trojans clinging to a precarious 13-12 lead over…
Why Is Everyone Ignoring Gilead Stock’s High Cash Yield?
Gilead Sciences (GILD) generated free cash flow equal to 7.1% of its market value over the last twelve months. The median S&P 500 company yielded just 4.5% over the same period. A yield that high means one of two things: the business is…
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Gilead Sciences (NASDAQ:GILD) and its peers. The 11 therapeutics stocks we track reported a very strong Q2. As…
Middle School Girls Volleyball Gilead Christian School - 10/09/2026 | Live & On Demand
Middle School Girls Volleyball Gilead Christian School - 10/09/2026 | Watch Live & On Demand NFHS Network Volleyball - Middle School Girls Middle School Girls Volleyball Gilead Christian School - 10/09/2026 | Watch Live & On Demand STREAM…
Is Extending the Gilead E3 Ligase Collaboration Altering The Investment Case For Nurix Therapeutics (NRIX)?
Nurix Therapeutics, Inc. recently announced that it has extended by two years the research term for an undisclosed oncology program under its ongoing collaboration with Gilead Sciences, originally established in 2019 to develop E3…
Gilead Sciences's Q1 2026 Earnings: What to Expect
Foster City, California-based Gilead Sciences, Inc. (GILD) discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States and internationally. The company has a market cap of $173 billion and…
Gilead Sciences signs five-year DevOps agreement with Cognizant
Gilead Sciences has signed a five-year agreement extension with Cognizant to advance its DevOps environment and support the deployment of agentic AI tools across designated technology initiatives. The renewed arrangement will see Cognizant…
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. Under the agreement, Cognizant will support…
Cognizant Drives AI-Led DevOps Innovation for Gilead Sciences
WEDNESDAY, 7 OCTOBER 2026 Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. Under the agreement,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com174
-
tradingview.com114
-
finance.yahoo.com110
-
themarketsdaily.com72
-
ca.finance.yahoo.com49
Measured across the 4Chattanooga news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.